Member Info for Soupdragon78

Hugo, they wouldn't issue a correction even if it turned out to be false. Newspapers print what people want them to print.

Check out the metadata from the article and you'll see where it comes from. ;-)

Converting not concerting

Biboergo, it wasn’t Miller concerting yesterday. It was old warrants.

Thanks Geordieshores, you didn’t by any chance go over to Eurasia did you?

Thanks Geordie, so to summarise, you sold because it didn't go the way you wanted.

Well done.

Exactly Cdub, its just folk chasing each other around trying to bank fifty quid here or there.

Weighted average here of 2.4p which shows what patience brings.

Screech, wrong Julian Higgins, it’s not the one you think it is. It’s a hedge fund manager.

Cdub, Kirk hasn't been involved with CPI since August 2018 so them selling is not related.

He has been a freelance consultant for a number of years and was always Non-Exec at Nuformix, so not key to day to day running.

Cdub, don't go by what people have on their linkedin account. I know people who left my company over 5 years ago who still haven't changed their linkedin to reflect that.

Kirk was a company officer so had to inform companies house. That is the one source you should use.

https://beta.companieshouse.gov.uk/company/09632100/officers

Also note, Roger Jones being made Company Secretary last Friday in lieu of SGH.

Yorkshireboy, as someone who has been in NFX and posted here since December 2017 I am aware of the physiognomies involved and yet seen many people try to hide behind the science. Yet none will put a reasoning to their words usually because they don’t even understand the patents they post.
Have you figured out who the people behind Ebers are?

Yorkshireboy, those patents are from 2011, what’s the relevance?

Thanks Shady, the Ebers deal post year end. Dan has said in interview that the upfront payment (the deal RNS stated 'a significant upfront payment') was made of £500k.

The company was expecting £3.4m in H1 this financial year, so up to end of Sept 2019. This comprised of:
£500k NXP001 milestone.
£500k Ebers payment
£2m NXP001 clinic trial success.
£400k - I don't know what this relates to.

If we take it that they have received circa £1m from Ebers and NXP001 milestone. (Again in interview Dan said they are seeking the 'remaining £2m', hence the assumption the milestone 500k was paid) Then they can be seen to have covered costs for the year already.

Furthermore, the annual report states that they have provided forward cashflow plans to show how they will operate through the year, even with delayed payments.

On a separate note, who undertakes a placing for a company?

ps. Shady, you say that they need the 2m payment. This means you acknowledge they have had 500k from NSB.

Now we know that they also received a 500k upfront payment from Ebers as well.

Plus they got paid for the patent filing.

Shady, last years wage bill was circa 350k.

So if its the same so far this year they will have spent 175k of salaries.

Shady, how much have they received post results?

Drax, how would you determine 'very positive' for the RNS? What parameters are you setting?

LB28, not all hospitals have the equipment or need the equipment that uses StoneChecker.

Thanks LB28, we know that their selling price point is around 75-100k from preview interviews. So I guess we will have to find how much their margin is and how much comes back to IQAI.

LB28, how much do IQAI make per sale of Stonechecker?